Sign in

    Michael TaglichTaglich Brothers

    Michael N. Taglich is Co-Founder, President, and Chairman of Taglich Brothers, Inc., a New York-based broker-dealer specializing in small-cap and mid-cap equities, with particular expertise across sectors such as healthcare, industrials, and technology. Over his career spanning more than two decades, Taglich has covered and served on the boards of companies including Intellinetics (INLX), SCOLR Pharma, BioVentrix, Dilon Technologies, and AutoNet, with a reputation for value creation and leading successful SaaS and growth transitions. He began his career in the 1990s, founding Taglich Brothers and serving on multiple public company boards, and has maintained ongoing leadership, overseeing both investment banking and securities research at the firm. Taglich holds FINRA registrations and is listed on BrokerCheck, reflecting his compliance with industry licensing and standards, and he is recognized for his strategic acumen and governance expertise within small-cap markets.

    Michael Taglich's questions to BGSF Inc (BGSF) leadership

    Michael Taglich's questions to BGSF Inc (BGSF) leadership • Q1 2025

    Question

    Michael Taglich of Taglich Brothers asked if management was comfortable with current Street estimates for the year and requested a description of how the company is tracking against its internal plan for the second quarter.

    Answer

    Executive Keith Schroeder noted that the company beat Q1 estimates on revenue, net income, and EPS, but would need to review updated Q2 estimates before commenting further. CEO Beth Garvey stated the company is "tracking where we thought we were going to be," expressing cautious optimism and a belief that both divisions have positive momentum and are moving in the right direction.

    Ask Fintool Equity Research AI